NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Authors

William Hall

William A. Hall

Medical College of Wisconsin, Milwaukee, WI

William A. Hall , Theodore Karrison , Bradley Alexander McGregor , Pedro C. Barata , Himanshu Nagar , Chad Tang , shankar siva , Todd Matthew Morgan , Joshua Michael Lang , Carri Glide-Hurst , Sophia C. Kamran , Karthik Sundaram , Sharyn I. Katz , Felix Y Feng , Rana R. McKay

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS4613)

DOI

10.1200/JCO.2024.42.16_suppl.TPS4613

Abstract #

TPS4613

Poster Bd #

305a

Abstract Disclosures

Similar Posters

First Author: Basel M Altoos

First Author: Atul Batra

First Author: Kanwal Pratap Singh Raghav